| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.01 | 1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.0072 | 1 |